[Form 4] Snowflake Inc. Insider Trading Activity
Rhea-AI Filing Summary
Frank Slootman, a Snowflake Inc. director, executed stock option exercises and multiple open-market sales under a 10b5-1 plan on 08/28/2025. He exercised 710,083 stock options with an $8.88 exercise price, resulting in 710,083 shares from the option exercise. On the same date he sold multiple blocks of common stock in separate transactions at weighted-average prices reported across several price ranges (examples shown from $225.00 up to $236.71 depending on the block). The Form 4 discloses direct and indirect holdings across entities and trusts, including shares held directly and by Invisible Hand Ventures LLC, the Slootman Family Foundation, and several trusts. The reported transactions were effected pursuant to a 10b5-1 trading plan adopted March 26, 2025.
Positive
- Exercise of options at a low strike of $8.88 indicates potential long-term prior compensation alignment
- Trades executed under a 10b5-1 plan, providing pre-established timing and regulatory affirmative defense
- Complete disclosure of indirect holdings (LLC, foundation, multiple trusts) improves transparency on beneficial ownership
Negative
- Significant share sales on the same date as the exercise reduce the director's direct share count and represent insider liquidity
- Multiple large tranches sold across price bands may be viewed as material insider selling activity by some investors
Insights
TL;DR: Director exercised a large block of $8.88 options and sold shares across multiple price bands under a 10b5-1 plan.
The filings show a material option exercise of 710,083 options at an $8.88 strike and contemporaneous share sales executed in multiple tranches at weighted-average prices spanning roughly $225 to $236.71. The activity was implemented under a pre-established 10b5-1 plan, which indicates the trades were pre-programmed rather than opportunistic. The Form 4 also details retained direct and indirect ownership across an LLC, foundation, and several trusts, which matters for ongoing insider ownership calculations. For investors tracking insider liquidity or potential dilution from exercised options, these are clear, documented changes to beneficial ownership on 08/28/2025.
TL;DR: Transaction is routine insider liquidity under an adopted trading plan; governance disclosure is complete on beneficial ownership.
The Form 4 includes the required disclosures: exercise details, multiple sale tranches with weighted-average prices, and explicit descriptions of indirect holdings (Invisible Hand Ventures LLC and several trusts and a foundation). The filer noted the 10b5-1 plan adoption date (March 26, 2025), which supports the affirmative defense condition. The signature by an attorney-in-fact is present. The filing provides the explanatory footnotes necessary for clarity on vesting and ownership form, meeting regulatory disclosure norms.